Authors:
Frissen, PHJ
de Vries, J
Weigel, HM
Brinkman, K
Citation: Phj. Frissen et al., Severe anaphylactic shock after rechallenge with abacavir without preceding hypersensitivity, AIDS, 15(2), 2001, pp. 289-289
Authors:
Frissen, PHJ
de Vries, J
Weigel, HM
Brinkman, K
Citation: Phj. Frissen et al., Reply to 'The abacavir hypersensitivity reaction and interruptions in therapy' by A. Edde Loeliger, Helen Steel, Sue McGuirk, Wendy S. Powell and Seth V. Hetherington, AIDS, 15(10), 2001, pp. 1326-1326
Authors:
Gartland, M
Gerstoft, J
Goebel, F
Clumeck, N
Cooper, DA
Gatell, J
Gazzard, B
Gerstoft, J
Goebel, F
Lange, J
Montaner, J
Reiss, P
Rozenbaum, W
Vella, S
Beveridge, A
Cooper, DA
Duncombe, C
Gold, J
Haberl, M
Clumeck, N
Luyts, D
Montaner, J
Rachlis, A
Marina, R
Gerstoft, J
Wandall, JH
Elbrond, B
Molina, JM
Pialloux, G
Rozenbaum, W
Beauvais, L
Goebel, FD
Staszewski, S
Bruns, I
Hug, M
Reiss, P
Lange, J
Frissen, PHJ
van der Ende, ME
Bosboom, M
Baas, C
Milazzo, F
Moroni, M
Panebianco, R
Clotet, B
Artigas, JMG
Gonzalez-Lahoz, J
Leal, M
Rodriguez-Lopo, C
Gandarias, B
Gazzard, B
Johnson, M
McKinley, S
Page, V
Watkins, K
Sandstrom, E
Belsey, E
Darbyshire, J
Chodakewitz, J
Isaacs, R
Jonas, L
Meibohm, A
Coughlan, M
Fiddian, P
Gartland, M
Harrigan, R
Larder, B
Maguire, M
Millard, J
Moore, S
Patel, K
Shortino, D
Tisdale, M
Vafidis, I
Yeo, J
Citation: M. Gartland et al., AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients, AIDS, 14(4), 2000, pp. 367-374
Citation: Hd. Boyraz-ikiz et al., Cytomegalovirus (re)activation plays no role in the ocular vitritis observed after initiation of highly active antiretroviral therapy, AIDS, 13(7), 1999, pp. 867-867